In this work, we developed an enzymatic voltammetric biosensor for the determination of catechin and gallic acid in green tea and kombucha samples. The differential pulse voltammetry (DPV) methodology was optimized regarding the amount of crude enzyme extract, incubation time in the presence of the substrates, optimal pH, reuse of the biosensor, and storage time. Samples of green tea and kombucha were purchased in local markets in the city of Goiânia-GO, Brazil. High performance liquid chromatography (HPLC) and Folin-Ciocalteu spectrophotometric techniques were performed for the comparison of the analytical methods employed. In addition, two calibration curves were made, one for catechin with a linear range from 1 to 60 µM (I = −0.152 * (catechin) − 1.846), with a detection limit of 0.12 µM and a quantification limit of 0.38 µM and one for gallic acid with a linear range from 3 to 60 µM (I = −0.0415 * (gallic acid) − 0.0572), with a detection limit of 0.14 µM and a quantification limit of 0.42 µM. The proposed biosensor was efficient in the determination of phenolic compounds in green tea.
The binding between anticancer drugs and double-stranded DNA (dsDNA) is a key issue to understand their mechanism of action, and many chemical methods have been explored on this task. Molecular docking techniques successfully predict the affinity of small molecules into the DNA binding sites. In turn, various DNA-targeted drugs are electroactive; in this regard, their electrochemical behavior may change according to the nature and strength of interaction with DNA. A carbon paste electrode (CPE) modified with calf thymus ds-DNA (CPDE) and computational methods were used to evaluate the drug–DNA intercalation of doxorubicin (DOX), daunorubicin (DAU), idarubicin (IDA), dacarbazine (DAR), mitoxantrone (MIT), and methotrexate (MTX), aiming to evaluate eventual correlations. CPE and CPDE were immersed in pH 7 0.1 mM solutions of each drug with different incubation times. As expected, the CPDE response for all DNA-targeted drugs was higher than that of CPE, evidencing the drug–DNA interaction. A peak current increase of up to 10-fold was observed; the lowest increase was seen for MTX, and the highest increase for MIT. Although this increase in the sensitivity is certainly tied to preconcentration effects of DNA, the data did not agree entirely with docking studies, evidencing the participation of other factors, such as viscosity, interfacial electrostatic interactions, and coefficient of diffusion.
Different starch properties may cause alterations in the foodstuff’s external appearance. However, modification processes in starches are usually secretive. The use of chemically modified starches is regulated by international standards, which makes it important to identify its presence and type. Mid-infrared spectroscopy (MIR)-modified starches’ identification can be hindered by the presence of excess glucose. This research investigates types of modification in commercial starches and in approaches that circumvent MIR’s limitations with exploratory analysis. It also considers that enzymatic hydrolysis (α-amylase and amyloglucosidase) can highlight the points of modification in the structure, which can be detected with infrared assays. To determine if sour cassava starch (FCS) is modified and check its type, six samples were selected: a native one, three of the most common cassava modified starches (etherified, esterified, and FCS), and two laboratory processed samples (Acid, Oxidized). The results showed that the sour cassava starch showed similarities with a commercial ester and an oxidized cassava starch, which may be due to the formation of a graft, corresponding to what the literature has already reported for corn starch treated with lactic acid and gamma radiation.
28 April 2026 in Brazilian Journal of Analytical Chemistry
Gatifloxacin (GAT), a fourth-generation antimicrobial agent, requires stringent quality control measures in human medication. Electroanalysis offers a cost-effective method for quality control, showing promise for drug analyses. In this study, GAT eye drops were analyzed using differential pulse voltammetry (DPV) with a BiVO4-modified carbon paste electrode (CPE). The electrochemical characterization of GAT involved a pH study, determining pH 7.0 as optimal with an anodic oxidation process at 0.88 V. The anodic peak suggested equivalence between protons and electrons, with a Nernstian-like slope of around 59 mV. pH-1 in the Epa vs. pH plot. Subsequent assays using PBS at pH 7.0 showed promising results. The electroanalytical method exhibited precision and accuracy that were suitable for the intended purpose. CPE/BiVO4 provided a low-cost, versatile, and rapid alternative for GAT quantification in pharmaceutical formulations, indicating the potential for analyzing other drugs in complex matrices. Subsequent voltammetric assays were carried out using PBS at pH 7.0. Further tests demonstrated a linear correlation between GAT concentration and current intensity (r2 = 0.99), with an LOD of 0.07 µM and LOQ of 0.23 µM. Precision testing confirmed the method’s reliability, showing a relative standard deviation of 1.28% and 1.48% for intra-day and inter-day precision, respectively. The CPE/BiVO4 method proved accurate, precise, and reproducible, offering a low-cost and versatile alternative for GAT quantification in pharmaceutical formulations. The findings suggest the potential application of this electroanalytical approach for drug analysis in complex biological matrices, showing promise for the quantification of other pharmaceuticals.